Do analysts rate ALP or IPM?

Portage Biotech presently has a consensus price target of $12.50, suggesting a potential upside of 303.23%. Given Portage Biotech's stronger consensus rating and higher possible upside, research analysts plainly believe Portage Biotech is more favorable than Intelligent Protection Management. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Portage Biotech 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67 Intelligent Protection Management 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Do analysts prefer ALP or BIRD?

Portage Biotech currently has a consensus target price of $12.50, suggesting a potential upside of 303.23%. Given Portage Biotech's stronger consensus rating and higher probable upside, equities research analysts plainly believe Portage Biotech is more favorable than Allbirds. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Portage Biotech 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67 Allbirds 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Do analysts prefer ALP or AZIO?

Portage Biotech presently has a consensus target price of $12.50, indicating a potential upside of 303.23%. Given Portage Biotech's stronger consensus rating and higher probable upside, analysts clearly believe Portage Biotech is more favorable than Envirotech Vehicles. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Portage Biotech 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67 Envirotech Vehicles 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is ALP or AZIO more profitable?

Portage Biotech has a net margin of 0.00% compared to Envirotech Vehicles' net margin of -331.76%. Company Net Margins Return on Equity Return on Assets Portage Biotech N/A N/A N/A Envirotech Vehicles -331.76% N/A -219.83%

Do analysts prefer ALP or ALIS?

Portage Biotech currently has a consensus price target of $12.50, indicating a potential upside of 303.23%. Given Portage Biotech's stronger consensus rating and higher probable upside, analysts clearly believe Portage Biotech is more favorable than Calisa Acquisition. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Portage Biotech 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67 Calisa Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation and earnings, ALP or ALIS?

Calisa Acquisition has lower revenue, but higher earnings than Portage Biotech. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Portage Biotech $100K 48.05 -$38.63M -$409.00 N/A Calisa Acquisition N/A N/A N/A N/A N/A

Is ALP or ALIS more profitable?

Company Net Margins Return on Equity Return on Assets Portage Biotech N/A N/A N/A Calisa Acquisition N/A N/A N/A

Do analysts rate ALP or CORZZ?

Portage Biotech presently has a consensus price target of $12.50, indicating a potential upside of 303.23%. Given Portage Biotech's stronger consensus rating and higher probable upside, equities research analysts clearly believe Portage Biotech is more favorable than Core Scientific. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Portage Biotech 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67 Core Scientific 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher valuation and earnings, ALP or CORZZ?

Core Scientific has higher revenue and earnings than Portage Biotech. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Portage Biotech $100K 48.05 -$38.63M -$409.00 N/A Core Scientific $592.07M N/A N/A N/A N/A

Is ALP or CORZZ more profitable?

Company Net Margins Return on Equity Return on Assets Portage Biotech N/A N/A N/A Core Scientific N/A N/A N/A

Portage Biotech (ALP) Competitors

$3.10 -0.14 (-4.32%)

As of 11/12/2026 04:00 PM Eastern

Compare

ALP vs. IPM, BIRD, AZIO, ALIS, and CORZZ

Should you buy Portage Biotech stock or one of its competitors? Portage Biotech's main competitors and comparable companies include Intelligent Protection Management (IPM), Allbirds (BIRD), Envirotech Vehicles (AZIO), Calisa Acquisition (ALIS), and Core Scientific (CORZZ). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "internet services & infrastructure" industry.

How does Portage Biotech compare to Intelligent Protection Management?

Portage Biotech (NASDAQ:ALP) and Intelligent Protection Management (NASDAQ:IPM) are both small-cap technology companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, dividends, earnings, valuation, profitability, risk and institutional ownership.

Intelligent Protection Management has higher revenue and earnings than Portage Biotech. Intelligent Protection Management is trading at a lower price-to-earnings ratio than Portage Biotech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Portage Biotech	$100K	48.05	-$38.63M	-$409.00	N/A
Intelligent Protection Management	$23.61M	0.67	-$1.96M	-$0.28	N/A

In the previous week, Intelligent Protection Management had 6 more articles in the media than Portage Biotech. MarketBeat recorded 7 mentions for Intelligent Protection Management and 1 mentions for Portage Biotech. Portage Biotech's average media sentiment score of 1.82 beat Intelligent Protection Management's score of 0.56 indicating that Portage Biotech is being referred to more favorably in the media.

Company	Overall Sentiment
Portage Biotech	Very Positive
Intelligent Protection Management	Positive

Portage Biotech presently has a consensus price target of $12.50, suggesting a potential upside of 303.23%. Given Portage Biotech's stronger consensus rating and higher possible upside, research analysts plainly believe Portage Biotech is more favorable than Intelligent Protection Management.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Portage Biotech	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Intelligent Protection Management	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Portage Biotech has a net margin of 0.00% compared to Intelligent Protection Management's net margin of -11.45%. Portage Biotech's return on equity of 0.00% beat Intelligent Protection Management's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Portage Biotech	N/A	N/A	N/A
Intelligent Protection Management	-11.45%	-19.21%	-11.10%

Portage Biotech has a beta of 0.65, suggesting that its stock price is 35% less volatile than the broader market. Comparatively, Intelligent Protection Management has a beta of 1.75, suggesting that its stock price is 75% more volatile than the broader market.

13.4% of Portage Biotech shares are owned by institutional investors. Comparatively, 3.9% of Intelligent Protection Management shares are owned by institutional investors. 20.8% of Intelligent Protection Management shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Portage Biotech beats Intelligent Protection Management on 8 of the 14 factors compared between the two stocks.

How does Portage Biotech compare to Allbirds?

Portage Biotech (NASDAQ:ALP) and Allbirds (NASDAQ:BIRD) are both small-cap technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, media sentiment, dividends, valuation and earnings.

Portage Biotech has a net margin of 0.00% compared to Allbirds' net margin of -72.82%. Portage Biotech's return on equity of 0.00% beat Allbirds' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Portage Biotech	N/A	N/A	N/A
Allbirds	-72.82%	-231.86%	-81.53%

13.4% of Portage Biotech shares are held by institutional investors. Comparatively, 44.1% of Allbirds shares are held by institutional investors. 18.8% of Allbirds shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Portage Biotech currently has a consensus target price of $12.50, suggesting a potential upside of 303.23%. Given Portage Biotech's stronger consensus rating and higher probable upside, equities research analysts plainly believe Portage Biotech is more favorable than Allbirds.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Portage Biotech	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Allbirds	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Portage Biotech has a beta of 0.65, meaning that its share price is 35% less volatile than the broader market. Comparatively, Allbirds has a beta of 2.63, meaning that its share price is 163% more volatile than the broader market.

Portage Biotech has higher earnings, but lower revenue than Allbirds. Allbirds is trading at a lower price-to-earnings ratio than Portage Biotech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Portage Biotech	$100K	48.05	-$38.63M	-$409.00	N/A
Allbirds	$152.47M	0.06	-$77.28M	-$8.99	N/A

In the previous week, Portage Biotech and Portage Biotech both had 1 articles in the media. Portage Biotech's average media sentiment score of 1.82 beat Allbirds' score of 1.79 indicating that Portage Biotech is being referred to more favorably in the media.

Company	Overall Sentiment
Portage Biotech	Very Positive
Allbirds	Very Positive

Summary

Portage Biotech beats Allbirds on 8 of the 13 factors compared between the two stocks.

How does Portage Biotech compare to Envirotech Vehicles?

Portage Biotech (NASDAQ:ALP) and Envirotech Vehicles (NASDAQ:AZIO) are both small-cap technology companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, media sentiment, dividends, valuation and earnings.

13.4% of Portage Biotech shares are owned by institutional investors. Comparatively, 5.7% of Envirotech Vehicles shares are owned by institutional investors. 9.6% of Envirotech Vehicles shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Portage Biotech has a beta of 0.65, meaning that its share price is 35% less volatile than the broader market. Comparatively, Envirotech Vehicles has a beta of 1.07, meaning that its share price is 7% more volatile than the broader market.

Portage Biotech has higher earnings, but lower revenue than Envirotech Vehicles. Envirotech Vehicles is trading at a lower price-to-earnings ratio than Portage Biotech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Portage Biotech	$100K	48.05	-$38.63M	-$409.00	N/A
Envirotech Vehicles	$5.94M	1.66	-$39.13M	-$4.90	N/A

In the previous week, Envirotech Vehicles had 3 more articles in the media than Portage Biotech. MarketBeat recorded 4 mentions for Envirotech Vehicles and 1 mentions for Portage Biotech. Portage Biotech's average media sentiment score of 1.82 beat Envirotech Vehicles' score of 0.60 indicating that Portage Biotech is being referred to more favorably in the media.

Company	Overall Sentiment
Portage Biotech	Very Positive
Envirotech Vehicles	Positive

Portage Biotech has a net margin of 0.00% compared to Envirotech Vehicles' net margin of -331.76%.

Company	Net Margins	Return on Equity	Return on Assets
Portage Biotech	N/A	N/A	N/A
Envirotech Vehicles	-331.76%	N/A	-219.83%

Portage Biotech presently has a consensus target price of $12.50, indicating a potential upside of 303.23%. Given Portage Biotech's stronger consensus rating and higher probable upside, analysts clearly believe Portage Biotech is more favorable than Envirotech Vehicles.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Portage Biotech	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Envirotech Vehicles	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Portage Biotech beats Envirotech Vehicles on 8 of the 13 factors compared between the two stocks.

How does Portage Biotech compare to Calisa Acquisition?

Portage Biotech (NASDAQ:ALP) and Calisa Acquisition (NASDAQ:ALIS) are both technology companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, risk, media sentiment, valuation, dividends, profitability, analyst recommendations and institutional ownership.

13.4% of Portage Biotech shares are owned by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Company	Net Margins	Return on Equity	Return on Assets
Portage Biotech	N/A	N/A	N/A
Calisa Acquisition	N/A	N/A	N/A

Calisa Acquisition has lower revenue, but higher earnings than Portage Biotech.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Portage Biotech	$100K	48.05	-$38.63M	-$409.00	N/A
Calisa Acquisition	N/A	N/A	N/A	N/A	N/A

Portage Biotech currently has a consensus price target of $12.50, indicating a potential upside of 303.23%. Given Portage Biotech's stronger consensus rating and higher probable upside, analysts clearly believe Portage Biotech is more favorable than Calisa Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Portage Biotech	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Calisa Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Portage Biotech and Portage Biotech both had 1 articles in the media. Portage Biotech's average media sentiment score of 1.82 equaled Calisa Acquisition'saverage media sentiment score.

Company	Overall Sentiment
Portage Biotech	Very Positive
Calisa Acquisition	Very Positive

Summary

Portage Biotech beats Calisa Acquisition on 4 of the 4 factors compared between the two stocks.

How does Portage Biotech compare to Core Scientific?

Portage Biotech (NASDAQ:ALP) and Core Scientific (NASDAQ:CORZZ) are both technology companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and profitability.

In the previous week, Core Scientific had 2 more articles in the media than Portage Biotech. MarketBeat recorded 3 mentions for Core Scientific and 1 mentions for Portage Biotech. Portage Biotech's average media sentiment score of 1.82 beat Core Scientific's score of 0.46 indicating that Portage Biotech is being referred to more favorably in the media.

Company	Overall Sentiment
Portage Biotech	Very Positive
Core Scientific	Neutral

Core Scientific has higher revenue and earnings than Portage Biotech.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Portage Biotech	$100K	48.05	-$38.63M	-$409.00	N/A
Core Scientific	$592.07M	N/A	N/A	N/A	N/A

Portage Biotech presently has a consensus price target of $12.50, indicating a potential upside of 303.23%. Given Portage Biotech's stronger consensus rating and higher probable upside, equities research analysts clearly believe Portage Biotech is more favorable than Core Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Portage Biotech	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Core Scientific	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Company	Net Margins	Return on Equity	Return on Assets
Portage Biotech	N/A	N/A	N/A
Core Scientific	N/A	N/A	N/A

13.4% of Portage Biotech shares are held by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Portage Biotech beats Core Scientific on 4 of the 6 factors compared between the two stocks.

Get Portage Biotech News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ALP vs. The Competition

Export

Metric	Portage Biotech	IT Services Industry	Technology Sector	NASDAQ Exchange
Market Cap	$5.02M	$10.55B	$27.60B	$12.24B
Dividend Yield	N/A	3.63%	2.89%	4.51%
P/E Ratio	N/A	32.75	41.65	29.04
Price / Sales	48.05	4.26	5.75	6.03
Price / Cash	N/A	22.36	27.75	22.80
Price / Book	0.22	4.43	5.43	3.83
Net Income	-$38.63M	$265.15M	$786.79M	$390.69M
7 Day Performance	3.33%	2.58%	2.73%	0.52%
1 Month Performance	-22.89%	-5.35%	-6.78%	-6.01%
1 Year Performance	-98.24%	-3.10%	3.83%	-5.24%

Portage Biotech Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ALP Portage Biotech	3.3257 of 5 stars	$3.10 -4.3%	$12.50 +303.2%	-98.4%	$5.02M	$100K	N/A	22	Positive News
IPM Intelligent Protection Management	1.738 of 5 stars	$1.72 +4.9%	N/A	-11.7%	$14.82M	$23.61M	N/A	53	Earnings Report Analyst Revision High Trading Volume
BIRD Allbirds	1.27 of 5 stars	$1.26 flat	N/A	-81.3%	$11.10M	$152.47M	N/A	200	Positive News Gap Down
AZIO Envirotech Vehicles	0.3069 of 5 stars	$0.59 +5.4%	N/A	-51.5%	$9.60M	$5.94M	N/A	10
ALIS Calisa Acquisition	N/A	$8.60 +1.5%	N/A	N/A	$0.00	N/A	N/A	3	Positive News Analyst Forecast Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ALP) was last updated on 11/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Portage Biotech (ALP) Competitors

ALP vs. IPM, BIRD, AZIO, ALIS, and CORZZ

How does Portage Biotech compare to Intelligent Protection Management?

Summary

How does Portage Biotech compare to Allbirds?

Summary

How does Portage Biotech compare to Envirotech Vehicles?

Summary

How does Portage Biotech compare to Calisa Acquisition?

Summary

How does Portage Biotech compare to Core Scientific?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALP vs. The Competition

Portage Biotech Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Portage Biotech (ALP) Competitors

ALP vs. IPM, BIRD, AZIO, ALIS, and CORZZ

How does Portage Biotech compare to Intelligent Protection Management?

Which has better earnings & valuation, ALP or IPM?

Does the media prefer ALP or IPM?

Do analysts rate ALP or IPM?

Is ALP or IPM more profitable?

Which has more risk and volatility, ALP or IPM?

Do institutionals and insiders hold more shares of ALP or IPM?

Summary

How does Portage Biotech compare to Allbirds?

Is ALP or BIRD more profitable?

Do institutionals & insiders have more ownership in ALP or BIRD?

Do analysts prefer ALP or BIRD?

Which has more volatility & risk, ALP or BIRD?

Which has better valuation and earnings, ALP or BIRD?

Does the media refer more to ALP or BIRD?

Summary

How does Portage Biotech compare to Envirotech Vehicles?

Do institutionals and insiders believe in ALP or AZIO?

Which has more volatility and risk, ALP or AZIO?

Which has higher earnings and valuation, ALP or AZIO?

Does the media refer more to ALP or AZIO?

Is ALP or AZIO more profitable?

Do analysts prefer ALP or AZIO?

Summary

How does Portage Biotech compare to Calisa Acquisition?

Do institutionals & insiders believe in ALP or ALIS?

Is ALP or ALIS more profitable?

Which has stronger valuation and earnings, ALP or ALIS?

Do analysts prefer ALP or ALIS?

Does the media prefer ALP or ALIS?

Summary

How does Portage Biotech compare to Core Scientific?

Does the media prefer ALP or CORZZ?

Which has higher valuation and earnings, ALP or CORZZ?

Do analysts rate ALP or CORZZ?

Is ALP or CORZZ more profitable?

Do insiders and institutionals hold more shares of ALP or CORZZ?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALP vs. The Competition

Portage Biotech Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools